NYSE: BBY

Best Buy Co., Inc.

Alpha Intelligence

Shareholder and Governance Insights

A public-information record of Q2 FY27 operating momentum, leadership transition and governance evidence boundaries.

Executive summary

Best Buy reported Q2 FY27 enterprise revenue of $9.779 billion, 4.1% comparable-sales growth and raised FY27 guidance. The public record also establishes planned CEO succession and a new CFO appointment. This report separates these issuer disclosures from proposed board questions and does not infer an Alpha rating or a complete AI-control environment.

Best BuyNYSE: BBY
Verified quoteTemporarily unavailable
Review evidence

Alpha view

The immediate board context is to connect the leadership transition and raised outlook to a dated, evidence-backed review of execution, risk and consequential AI use-case governance.

What changed
The issuer reported positive comparable-sales growth and raised FY27 guidance.
Why it matters
Best Buy reported Q2 FY27 enterprise revenue of $9.779 billion, 4.1% comparable-sales growth and raised FY27 guidance. The public record also establishes planned CEO succession and a new CFO appointment. This report separates these issuer disclosures from proposed board questions and does not infer an Alpha rating or a complete AI-control environment.
What the board should do
Tie transition, outlook and AI governance review to dated public and management evidence.
Decision signals

The five issues that carry the decision.

Direction, board relevance, and source health stay visible without reducing the analysis to an unexplained status color.

OperatingImproving
Observed

Comparable sales increased

The issuer reported 4.1% enterprise comparable-sales growth and raised FY27 guidance.

Materiality
Selected for the decision brief
Board relevance
Operating and market performance
Evidence health
1 linked, 1 primary · reviewed 2026-08-30
LeadershipWatch
Observed

CEO and CFO transition

The issuer disclosed CEO succession effective November 1, 2026 and a CFO appointment effective August 19, 2026.

Materiality
Selected for the decision brief
Board relevance
Board and committee oversight
Evidence health
2 linked, 1 primary · reviewed 2026-08-30
AI governanceWatch
Inferred

Public control detail remains bounded

Reviewed filings identify technology and AI risk context but do not establish a complete AI-use-case and control record.

Materiality
Selected for the decision brief
Board relevance
AI accountability and controls
Evidence health
2 linked, 2 primary · reviewed 2026-08-30
Earnings call intelligence

Q2 FY27 revenue was $9.779 billion, comparable sales increased 4.1%, and adjusted diluted EPS was $1.47.

The next observable test is Q3 FY27 reported performance against issuer guidance.

Next earnings
Not confirmed
AI narrative
0 direct mentions in the reviewed call
Analyst scrutiny
One dated secondary analyst action was verified. It is not consensus or an Alpha recommendation.
Open preparation items
1
Commitments due
Structured status history unavailable
Board agenda preview

Decisions requiring ownership and evidence.

Open the complete board agenda
Not available

Board action tracking is unavailable

The current public report does not contain structured decisions with owners and triggers. Alpha has not inferred them.

Key exhibits

Evidence that opens into the analysis.

Each exhibit links to its owning destination. Exact values and source paths remain attached.

Q2 performanceObserved

Q2 FY27 reported performance

Revenue
$9.779B
Comparable sales
+4.1%
Adjusted diluted EPS
$1.47

Static report facts are issuer-reported; the separate live provider overlay is outside this cutoff-bound visual.

GuidanceObserved

FY27 issuer guidance

Revenue
$42.3B–$42.8B
Comparable sales
+1.9%–+3.0%
Adjusted operating income rate
4.4%–4.5%

Forward-looking issuer guidance, not an Alpha forecast or recommendation.

2 / 9

Performance

BBY performance, expectations, and operating context.

Operating results, market performance, valuation, risk, and expectations.

Live provider data

Price, returns, benchmarks, and risk.

Exact dated series are shown when verified. Unavailable provider values are never substituted.

Not available

Market performance is being verified

The live provider has not returned a complete snapshot. No values were substituted.

Verifying live company and market data…

Market performance

Operating indicators, not a price call

This cutoff-bound analysis does not use a secondary quote or valuation feed; the report's separately labeled live provider overlay is current context, not evidence as of the publication cutoff.

Open detailed analysis and evidence1 finding
ObservedObserved

Q2 results improved

The issuer reported 4.1% comparable-sales growth and $1.47 adjusted diluted EPS.

Alpha takeaway

Use issuer-reported operating indicators and keep market-price assessment distinct.

Operating frame

Raised outlook follows reported Q2 execution

Best Buy raised FY27 revenue, comparable-sales and adjusted diluted-EPS guidance after Q2 results.

Open detailed analysis and evidence1 finding
ObservedObserved

FY27 outlook increased

The issuer raised FY27 comparable-sales guidance to 1.9% to 3.0% and adjusted diluted-EPS guidance to $6.70 to $6.90.

Alpha takeaway

Guidance is forward-looking management disclosure, not a conclusion about future performance.

Not available

valuation analysis is unavailable

The current public report does not contain a verified module for this topic. Alpha has not inferred one.

Decision exhibits

Market evidence in comparable form.

Verified report visuals keep the benchmark, exact values, interpretation, and source path together.

Q2 performanceObserved

Q2 FY27 reported performance

Why it matters: Static report facts are issuer-reported; the separate live provider overlay is outside this cutoff-bound visual.

View chart data and evidence
Accessible data for Q2 FY27 reported performance
ObservationValue
Revenue$9.779B
Comparable sales+4.1%
Adjusted diluted EPS$1.47
GuidanceObserved

FY27 issuer guidance

Why it matters: Forward-looking issuer guidance, not an Alpha forecast or recommendation.

View chart data and evidence
Accessible data for FY27 issuer guidance
ObservationValue
Revenue$42.3B–$42.8B
Comparable sales+1.9%–+3.0%
Adjusted operating income rate4.4%–4.5%

Risk

Technology, cyber and privacy risks remain material oversight inputs

The reviewed filings discuss technology, AI, cyber, privacy and related business risks.

Open detailed analysis and evidence1 finding

Alpha takeaway

Keep the disclosed risk perimeter tied to accountable owners, controls and escalation evidence.

Issuer FY27 EPS guidance

$6.70–$6.90August 27, 2026Management guidance

Observable company and ownership signals

Observable signals

3 / 9

Earnings Call Intelligence

Prepare the board for the next call.

Latest call, management narrative, disclosure signals, and market interpretation.

Issuer results and filings are cutoff-bound observed facts. No unverified price targets or consensus are used; a separately labeled live provider overlay may show current market context outside the static evidence cutoff.

Earnings analysis separates management statements, observable disclosure signals, and Alpha interpretation. Predictive language is calibrated and unsupported histories are omitted.

Earnings update · 2026-08-27

Latest reported quarter

Q2 FY27 revenue was $9.779 billion, comparable sales increased 4.1%, and adjusted diluted EPS was $1.47.

What changed, what the market heard, and what remains open · 2026-08-30

Executive Intelligence Brief

Findings separate observed evidence from Alpha interpretation. Analyst profiles summarize sourced participation and topics without assigning personality, motive, or private relationship labels.

Management ground truth

Q2 results and guidance changed

The issuer reported positive comparable-sales growth and raised FY27 guidance.
Source and context

Disclosure velocity and investor pressure · 2026-08-30

AI Disclosure & Analyst Attention

Reviewed the latest annual and quarterly filings and Q2 FY27 results for disclosed AI context. No earnings-call transcript count was independently verified.

FY26 Form 10-K

T2
N/Acount not assessed

Disclosure reviewed qualitatively; no automated mention count is asserted.

Source and context

Q1 FY27 Form 10-Q

T2
N/Acount not assessed

Disclosure reviewed qualitatively; no automated mention count is asserted.

Source and context

Inside the earnings call

Who drove the AI conversation?

Prepared remarks
0
Q&A
0
Analyst mentions
0
Management in Q&A
0

Analysts made 0 direct AI mentions across 0 question turns from 0 covering analysts.

Source and context

Wall Street attention

What analysts asked about

Source and context

Observed

The reviewed filings identify AI and technology in business and risk context.

Alpha inference

The public corpus does not establish a complete AI-use-case governance record.

Governance and next-call implication

A board-level evidence request can close the boundary without presuming a control failure.

Management ground truth

Management Signal Map

Financial performance

explicit
What management said

Management reported Q2 FY27 operating results and higher FY27 guidance.

Evidence

The Q2 FY27 release provides the stated values and ranges.

Tone shift

Issuer communication links results to raised annual guidance.

Still unresolved

Future operating outcomes remain unverified.

Source and context

Attributed interpretation

Market Narrative Synthesis

1

Market hearingmoderate evidence

Execution and transition

The public record makes operating delivery and leadership continuity observable board questions.
Support
Reported Q2 results, guidance and leadership disclosures.
What weakens it
Only one dated secondary analyst action was verified; no consensus series was used.
Source and context

Evidence discipline

Signal vs. Perception Gap Analysis

Signal vs. perception

AI governance evidence

medium gap
What was said

Filings identify technology and AI-related business risk context.

What was heard

A complete public control and use-case record is not established.

Interpretation risk

Absence from the reviewed set is not evidence of absent controls.

Mispriced opportunity

Publish decision-useful oversight and control evidence where appropriate.

Source and context
Not available

Earnings-call transcript is unavailable

No reviewed earnings-call transcript is attached to this public report. Filing and earnings-release analysis is shown without implying a reviewed call corpus.

Not available

Commitment follow-through is not yet tracked

The current report does not contain a structured history of management commitments, due dates, and later status. No completion state is inferred.

4 / 9

Wall Street Analysts

How analysts frame the company and where they will press next.

Coverage actions, persona analysis, thesis history, and next-call pressure tests.

Wall Street evidence is a dated public record of published recommendations, target actions, and call participation. Alpha adds source-linked interpretation to show what each analyst prioritizes and where the thesis may be tested next.

Sourced analyst facts remain attributed to the public record. Persona labels are Alpha interpretations of observable questioning posture and published stance, not psychological profiles, private motives, or relationship judgments.

Revision trend

Issuer outlook boundary

FY27 adjusted diluted EPS guidance

$6.70–$6.90

The issuer raised FY27 guidance; this report does not create an Alpha forecast.

Observed issuer guidanceMonitor future results against disclosed ranges.
Source and context

Alpha Intelligence

Alpha Market Interpretation

Alpha Intelligence capability

Governed public-market interpretation

Alpha structures source-linked market evidence into decision-useful signals. This published snapshot is fixed at the report evidence cutoff.
Engine
Alpha Intelligence
Model
alpha-market-interpretation-v1
Evidence cutoff
2026-08-30
Release state
publishable
Review state
evidence verified

Coverage composition

0 public analyst lenses0 firms, 1 dated action, and 3 linked evidence records define the observable coverage set.

Thesis convergence

1 evidence-linked theses1 unchanged

Revision frontier

1 next-call pressure tests
  1. Raised guidance and disclosed transition dates.Which leading indicators will management use to evaluate delivery of the raised FY27 outlook during the leadership transition?

Evidence gaps

Public evidence only
  • The named analyst action is limited to one dated secondary-provider snapshot; no consensus series was verified.
  • This analysis does not assess investment merit or produce an Alpha rating.

Governance implications

Evidence quality routes the next review
Transparency
moderate
Completeness
partial
Credibility
improving
Market Interpretation can trigger an evidence review. It does not alter AGR or GEH.

Observable actions

Covering Analysts and Latest Actions

FirmAnalystLatest stanceLatest actionPrice targetWhy it matters
UBSMichael LasserNeutralMaintained Neutral; price target raised from $86 to $90$90Dated secondary-provider observation following Q2 results; it is not an Alpha view.

One dated secondary analyst action was verified. It is not consensus or an Alpha recommendation.

Alpha analysis of sourced public participation and stated views

Analyst Persona Analysis

Each persona is Alpha's evidence-bound interpretation of the analyst's public call participation and published stance as of the report cutoff. It is not a psychological profile, statement of private motive, or relationship judgment.

Unavailable: no verified analyst persona.

Stated thesis versus execution evidence

Analyst Thesis and Question History

Unavailable: no verified named thesis.

Forward pressure test

Revision Frontier

1

Alpha-recommended question

Which leading indicators will management use to evaluate delivery of the raised FY27 outlook during the leadership transition?

Pressure point
Raised guidance and disclosed transition dates.
Possible asker
Public-market participant
The question follows from issuer disclosures and does not assume investor intent.Calibrated possibility, not a prediction.
Source and context

Decision use

Governance Implications

For management

For investors

Transparency quality

moderateReviewed filings and issuer releases provide an operating, proxy and transition record.

Disclosure completeness

partialThe reviewed corpus does not establish a complete enterprise AI governance and control record.

Credibility trajectory

improvingThe issuer reported Q2 growth and raised FY27 guidance; this is not a forecast.
5 / 9

Ownership

Shareholder structure, influence, and engagement opportunities.

Control, institutional holders, concentration, and shareholder opportunities.

Ownership

Use the filed ownership table

The latest definitive proxy is the public source for the ownership table reviewed in this report.

Open detailed analysis and evidence1 finding

Alpha takeaway

This report does not create a synthetic ownership register or infer voting authority beyond the filing.

Not available

Shareholder opportunities analysis is unavailable

The current public report does not contain a verified module for this topic. Alpha has not inferred one.

6 / 9

Governance

Board composition, accountability, and voting pressure.

Board composition, committee accountability, proxy evidence, and governance risk.

Governance

Transition is a current accountability context

Issuer disclosures identify a CEO succession and CFO appointment during the current reporting period.

Open detailed analysis and evidence1 finding

Alpha takeaway

The board can require a dated continuity and authority review without inferring transition risk.

Proxy

Annual-meeting record is available

The 2026 definitive proxy and subsequent Form 8-K establish the public shareholder-meeting evidence set.

Open detailed analysis and evidence1 finding

Alpha takeaway

Maintain the distinction among proposal, vote and board response evidence.

Governance exhibits

Vote pressure and the accountable response cycle.

Observed results remain separate from Alpha's inferred sequence for engagement, board response, and disclosure.

TransitionObserved

Publicly disclosed leadership dates

Why it matters: Dates are issuer disclosures; execution readiness is not assessed.

View chart data and evidence
Accessible data for Publicly disclosed leadership dates
ObservationValue
CFO appointment effective2026-08-19 complete
CEO succession effective2026-11-01 pending
7 / 9

AI

AI strategy, competitive advantage, workforce, and assurance.

Competitive position, business value, workforce transformation, accountability, controls, and evidence of operating effectiveness.

AI governance

Public disclosure supports questions, not a control conclusion

The reviewed filings do not establish a complete enterprise AI governance system.

Open detailed analysis and evidence1 finding

Alpha takeaway

Request a bounded inventory of consequential use cases, accountable owners, controls and escalation paths.

8 / 9

Board Agenda

Convert the evidence into accountable decisions.

Decisions, owners, triggers, required evidence, and questions for management.

Board agenda

Three evidence-linked requests

These are proposed questions, not mandates, assessments, or investment recommendations.

Open detailed analysis and evidence3 findings
RecommendationInferred

Review guidance drivers

Request the indicators that management will use to track delivery of raised FY27 guidance.

Alpha takeaway

Tie transition, outlook and AI governance review to dated public and management evidence.

9 / 9

Evidence

Source lineage, methodology, and current changes.

Change history, claim provenance, source records, definitions, and methodology.

Not available

A dated change ledger is unavailable

The evidence ledger remains available below. Alpha has not inferred a change history.

Evidence ledger

Every material claim has a usable source path.

Evidence cutoff Aug 30, 2026. Source authority is reported separately from claim status, confidence, jurisdiction, evidence date, and comparability. “Not publicly found” identifies a disclosure boundary and never automatically produces a zero governance score. Market values can change after the cutoff.

bby:q2-performanceObserved

Q2 FY27 revenue, comparable sales, EPS and operating margin.

1 / Securities filingVerified 2026-08-30
Best Buy Q2 FY27 results

Filed current-report exhibit covering Q2 FY27 results and guidance.

Claim status
Observed
Confidence
high
Jurisdiction
US
Evidence date
2026-08-27
Comparability
Directly comparable
2 / Securities filingVerified 2026-08-30
Best Buy FY26 Form 10-K

Annual filing covering identity, risks, governance and fiscal-year operations.

Claim status
Observed
Confidence
high
Jurisdiction
US
Evidence date
2026-03-18
Comparability
Directly comparable
3 / Securities filingVerified 2026-08-30
Best Buy 2026 definitive proxy statement

Filed proxy covering director elections, ownership, committees and executive compensation.

Claim status
Observed
Confidence
high
Jurisdiction
US
Evidence date
2026-04-30
Comparability
Directly comparable
4 / Securities filingVerified 2026-08-30
Best Buy 2026 annual-meeting results

Current report of shareholder voting at the June 2026 regular meeting.

Claim status
Observed
Confidence
high
Jurisdiction
US
Evidence date
2026-06-17
Comparability
Directly comparable
5 / Securities filingVerified 2026-08-30
Best Buy Q1 FY27 Form 10-Q

Filed quarterly operating, balance-sheet and risk disclosure.

Claim status
Observed
Confidence
high
Jurisdiction
US
Evidence date
2026-06-05
Comparability
Directly comparable
6 / Official operating disclosureVerified 2026-08-30
Best Buy CFO appointment release

Issuer release announcing Anne Bramman as CFO effective August 19, 2026.

Claim status
Observed
Confidence
high
Jurisdiction
US
Evidence date
2026-08-03
Comparability
Directly comparable
7 / Official operating disclosureVerified 2026-08-30
Best Buy corporate identity asset

Issuer-hosted Best Buy logo asset used in the report.

Claim status
Observed
Confidence
high
Jurisdiction
US
Evidence date
2026-08-30
Comparability
Directly comparable
8 / Secondary sourceVerified 2026-08-30
Benzinga BBY analyst-action snapshot

Dated secondary aggregation of public analyst actions; not an Alpha recommendation.

Claim status
Observed
Confidence
moderate
Jurisdiction
US
Evidence date
2026-08-28
Comparability
Directional only
9 / Alpha methodologyVerified 2026-08-30
Alpha methodology boundary

Public methodology boundary for the NR disclosure.

Claim status
Observed
Confidence
high
Jurisdiction
global
Evidence date
2026-08-30
Comparability
Directional only
10 / Secondary sourceVerified 2026-08-30
S&P 500 reference benchmark

Public index reference used as a comparison benchmark, not a membership claim.

Claim status
Observed
Confidence
high
Jurisdiction
US
Evidence date
2026-08-30
Comparability
Directional only